Daré Bioscience Statistics

Total Valuation

DARE has a market cap or net worth of $28.43 million. The enterprise value is $18.20 million.

Market Cap	28.43M
Enterprise Value	18.20M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

DARE has 100.58 million shares outstanding. The number of shares has increased by 3.23% in one year.

Shares Outstanding	100.58M
Shares Change (YoY)	+3.23%
Shares Change (QoQ)	-3.85%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	6.61%
Float	98.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.13
Forward PS	6.66
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	6.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.86

Current Ratio	0.86
Quick Ratio	0.61
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-120.80%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$122,082
Profits Per Employee	-$1.31M
Employee Count	23
Asset Turnover	0.11
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -72.28% in the last 52 weeks. The beta is 1.21, so DARE's price volatility has been higher than the market average.

Beta (1Y)	1.21
52-Week Price Change	-72.28%
50-Day Moving Average	0.46
200-Day Moving Average	0.49
Relative Strength Index (RSI)	27.05
Average Volume (30 Days)	360,780

Short Selling Information

The latest short interest is 235,035, so 0.23% of the outstanding shares have been sold short.

Short Interest	235,035
Short Previous Month	456,200
Short % of Shares Out	0.23%
Short % of Float	0.24%
Short Ratio (days to cover)	0.68

Income Statement

In the last 12 months, DARE had revenue of $2.81 million and -$30.16 million in losses. Loss per share was -$0.35.

Revenue	2.81M
Gross Profit	2.81M
Operating Income	-30.94M
Pretax Income	-30.16M
Net Income	-30.16M
EBITDA	-30.07M
EBIT	-30.16M
Loss Per Share	-$0.35

Full Income Statement

Balance Sheet

The company has $11.64 million in cash and $1.40 million in debt, giving a net cash position of $10.24 million or $0.10 per share.

Cash & Cash Equivalents	11.64M
Total Debt	1.40M
Net Cash	10.24M
Net Cash Per Share	$0.10
Equity / Book Value	-5.05M
Book Value Per Share	-0.05
Working Capital	-2.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$38.86 million and capital expenditures -$629,430, giving a free cash flow of -$39.49 million.

Operating Cash Flow	-38.86M
Capital Expenditures	-629,430
Free Cash Flow	-39.49M
FCF Per Share	-$0.45

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -1,101.89% and -1,074.17%.

Gross Margin	100.00%
Operating Margin	-1,101.89%
Pretax Margin	-1,074.17%
Profit Margin	-1,074.17%
EBITDA Margin	-1,070.88%
EBIT Margin	-1,074.17%
FCF Margin	-1,406.26%

Dividends & Yields

DARE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.23%
Shareholder Yield	-3.23%
Earnings Yield	-106.07%
FCF Yield	-138.87%

Analyst Forecast

The average price target for DARE is $6.00, which is 2,022.39% higher than the current price. The consensus rating is "Buy".

Price Target	$6.00
Price Target Difference	2,022.39%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	154.66%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 20, 2017. It was a reverse split with a ratio of 1:10.

Last Split Date	Jul 20, 2017
Split Type	Reverse
Split Ratio	1:10

Scores

DARE has an Altman Z-Score of -15.33. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.33
Piotroski F-Score	n/a